Journal
THERAPEUTIC DELIVERY
Volume 8, Issue 7, Pages 577-595Publisher
FUTURE SCI LTD
DOI: 10.4155/tde-2017-0020
Keywords
encapsulation; enzyme; nanocarrier; nanoparticle; targeted delivery
Categories
Funding
- Office of Naval Research through Core funds provided to the Naval Research Laboratory
- NRL Nanosciences Institute
Ask authors/readers for more resources
m Biotechnology has revolutionized therapeutics for the treatment of a wide range of diseases. Recent advances in protein engineering and material science have made the targeted delivery of enzyme therapeutics using nanocarriers (NCs) a new model of treatment. Several NCs have been approved for clinical use in drug delivery. Despite their advantages, few NCs have been approved to deliver enzyme cargo in a targeted manner. This review details the current arsenal of platforms developed to deliver enzyme therapeutics as well as the advantages and challenges of using enzymes as drugs, with examples from the literature, and discusses the benefits and liabilities of a given approach. We conclude by providing a perspective on how this field may evolve over the near and long-term.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available